Growing research points to potential long-term developmental implications of prenatal opioid exposure for children.
Reports
The EWA provides access to basic information on new psychoactive substances. Specific information on NPS including trend data, chemical...
LAPPA recently published a fact sheet in its Novel Psychoactive Substances series - Nitazenes. “Novel” substances are not never-before-seen...
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients
Lisa McElhaney / /Abstract In this cohort study of 537 patients, all patients with NPO overdose presented with opioid overdose symptoms and...
NDEWS Hotspot Alerts July 13 – Aug 23, 2023: Counties with an opioid alert in three or more weeks during the weeks of July 13th to August 23rd
Lisa McElhaney / /This week's NDEWS Hotspot Alerts report includes 31 counties with higher-than-expected drug-related 911 dispatch counts over the previous 7-day...
The Legislative Analysis and Public Policy Association examines state-level legislative and administrative responses to the public health risk posed...
Federal Register: Placement of Metonitazene in Schedule I - Final Order
The Rapid Street Reporting (RSR) team visited Los Angeles, CA on July 22–23, 2023.
The Rapid Street Reporting (RSR) team visited San Francisco, CA on July 19–21, 2023.
The Drug Enforcement Administration’s (DEA’s) National Forensic Laboratory Information System (NFLIS) is pleased to release the NFLIS-Drug Snapshot: June...
Trending Reports
- Trend Reports: cfsre NPS – Q1 2024 April 13, 2024
- NDEWS State Report: Alerts in New ork for 2023 April 12, 2024
- Federal Register: Placement of Etodesnitazene, NPyrrolidino Etonitazene, and Protonitazene in Schedule I April 11, 2024
- Federal Register: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I April 11, 2024
- NDEWS Hotspot Alerts March 21 – 27, 2024 April 5, 2024